09 In this episode of The GLP-1 Podcast Show, I speak with Dr
Those with severe arterial or nerve damage return to their previous baseline completely
Research in reputable journals such as the Journal of Clinical Endocrinology & Metabolism, Diabetes Care, and Nature has highlighted the potential risks of concurrent use, reinforcing the importance of caution and moderation
JL and H-GK supervised the research process and revised the manuscript for publication
Hives develop when the body releases histamine and other chemicals into the skin, triggering inflammation
While traditional treatments focus on glucose and lipid control, growing evidence suggests inflammation may continue Read More GLP-1 Adherence in the Real World: Why Patients Stop and How Clinicians Can Help Mar 17, 2026 Articles, Diabetes, GLP- 1 Agonist Therapy Center, GLP-1 Agonist Therapy Center, Type 2 Diabetes, Type 2 Diabetes 1,156 views Staying consistent with GLP-1 therapy remains one of the biggest challenges in diabetes management today
